In vivo cerebral pharmacokinetics and pharmaco-dynamics of diazepam and midazolam after short intravenous infusion administration in sheep

Journal of Pharmacokinetics and Pharmacodynamics

Volumn 28, Issue 2, 2001, Pages 129-153

  Upton, R N ^a   Ludbrook, G L ^a   Grant, C ^a   Martinez, A ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Cerebral blood flow; Cerebral pharmacokinetics; Diazepam; Lung pharmacokinetics; Midazolam; Pharmacodynamics

Indexed keywords

BENZODIAZEPINE RECEPTOR; DIAZEPAM; MIDAZOLAM;

ANIMAL EXPERIMENT; ARTICLE; BLOOD BRAIN BARRIER; BRAIN BLOOD FLOW; BRAIN CORTEX; CONTROLLED STUDY; DISSOCIATION; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; DRUG HALF LIFE; DRUG METABOLISM; DRUG UPTAKE; FEMALE; MEASUREMENT; NONHUMAN; PRIORITY JOURNAL; SHEEP;

ANIMALS; ANTI-ANXIETY AGENTS; CEREBRAL CORTEX; CEREBROVASCULAR CIRCULATION; DIAZEPAM; FEMALE; INFUSIONS, INTRAVENOUS; MIDAZOLAM; SHEEP;

EID: 0034753707     PISSN: 1567567X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1011550915515     Document Type: Article

References (44)

1. Benzodiazepines and their reversal
2. Intravenous anesthetic agents
3. Effect site equilibration time is a determinant of induction dose requirement
4. A model of the kinetics and dynamics of the induction of anesthesia in sheep. Variable estimation for thiopentone and comparison with propofol
5. Electroencephalographic effects of benzodiazepines. II. Pharmacodynamic modeling of the electroencephalographic effects of midazolam and diazepam
6. A pharmacokinetic/pharmacodynamic/receptor binding model to predict the onset and duration of pharmacological activity of benzodiazepines
7. In vivo relationships between the cerebral pharmacokinetics and pharmacodynamics of thiopentone in sheep after short-term administration
8. The blood and brain concentrations of propofol after rapid intravenous injection in sheep, and their relationships to cerebral effects
9. An ultrasonic Doppler venous outflow method for the continuous measurement of cerebral blood flow in conscious sheep
10. Agreement between estimates of cerebral blood flow changes in the sheep by a real-time ultrasonic Doppler venous outflow method and Kety Schmidt calculations based on 15 minutes nitrous oxide wash-in
11. A sheep preparation for studying interactions between blood flow and drug disposition I: Physiological profile
12. An assessment of the efficacy of intramuscular analgesics for acute pain in the sheep
13. The enantiomer specific kinetics and dynamics of verapamil after rapid intravenous administration to sheep - Physiological analysis and modeling
14. A method for frequent measurement of sedation and analgesia in sheep using the response to a ramped electrical stimulus
15. A physiological model of the induction of anesthesia with propofol in sheep. 1. Structure and estimation of parameters
16. The relationship between the myocardial kinetics of meperidine and its effect on myocardial contractility - Model independent analysis and optimal regional model
17. Effect of plasma protein binding on the uptake of methadone and diazepam in the isolated perfused rat lung
18. In vitro correlates of benzodiazepine cerebral spinal fluid uptake, pharmacodynamic action and peripheral distribution
19. The pharmacokinetics of diazepam and desmethyldiazepam in rat brain and plasma
20. Entry of diazepam and its major metabolite into cerebrospinal fluid
21. Ketamine and midazolam decrease cerebral blood flow and consequently their own rate of transport to the brain: An application of mass balance pharmacokinetics with a changing regional blood flow
22. Prediction of diazepam disposition in the rat and man by a physiologically based pharmacokinetic model
23. Determinants of benzodiazepine brain uptake: Lipophilicity vs. binding affinity
24. Effect of age, body composition, and lipid solubility on benzodiazepine tissue distribution in rats
25. Determination of steady state tissue distribution of midazolam in the rat
26. Concepts basic to pharmacokinetics
27. Pharmacokinetic-pharmacodynamic modeling of the electroencephalographic effects of benzodiazepines. Correlation with receptor binding and anticonvulsant activity
28. Pharmacodynamic interaction between midazolam and a low dose of ethanol in vivo
29. Midazolam kinetics
30. Pharmacokinetic-pharmacodynamic modeling of the central nervous system effects of midazolam and its main metabolite alpha-hydroxymidazolam in healthy volunteers
31. Pharmacokinetic-EEG effect relationship of midazolam in aging BN/BiRij rats
32. Pharmacokinetics of midazolam in patients recovering from cardiac surgery
33. Pharmacokinetics and plasma binding of diazepam in man, dog, rabbit, guinea pig and rat
34. Effects of protein binding and experimental disease states on brain uptake of benzodiazepines in rats
35. Development of an in situ mouse brain perfusion model and its application to mdrla p-glycoprotein-deficient mice
36. Modulators and substrates of p-glycoprotein and cytochrome P4503A coordinately up-regulate these proteins in human colon carcinoma cells
37. Effects of a potent and specific p-glycoprotein inhibitor on the blood-brain barrier distribution and antinociceptive effect of morphine in the rat
38. Pharmacokinetic and electroencephalographic study of intravenous diazepam, midazolam, and placebo
39. Simultaneous modeling of the pharmacokinetics and pharmacodynamics of midazolam and diazepam
40. Pharmacodynamic modeling of thiopental anesthesia
41. Relevance of arteriovenous concentration differences in pharmacokinetic-pharmacodynamic modeling of midazolam
42. Pharmacodynamic modeling of the electroencephalographic effects of flumazenil in healthy volunteers sedated with midazolam
43. The distribution and role of cytochrome P-450 in extrahepatic organs